老虎證券

BRIEF-Zai Lab, Vertex Sign Strategic Agreement To Develop, Commercialize Povetacicept In Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region And Singapore

Reuters
01-10
BRIEF-Zai Lab, Vertex Sign Strategic Agreement To Develop, Commercialize Povetacicept In Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region And Singapore

Jan 10 (Reuters) - Zai Lab Ltd 9688.HK:

  • ZAI LAB AND VERTEX ANNOUNCE STRATEGIC AGREEMENT TO DEVELOP AND COMMERCIALIZE POVETACICEPT IN MAINLAND CHINA, HONG KONG SAR, MACAU SAR, TAIWAN REGION AND SINGAPORE

  • ZAI LAB LTD - VERTEX TO RECEIVE UPFRONT PAYMENT, MILESTONE PAYMENTS, AND ROYALTIES

  • ZAI LAB LTD - TO HANDLE COMMERCIALIZATION ACTIVITIES FOR POVETACICEPT

Source text: nBw9wZyS4a

Further company coverage: 9688.HK

((Reuters.Briefs@thomsonreuters.com;))

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10